Galicia has approved a €15.6 million investment to supply gene therapy for hemophilia B, becoming the first region in Spain to do so. The therapy, Etranacogene...
Galicia complements the European funds received with €4.8 million of its own funds. The value for which these seven pieces of equipment were acquired exceeds €8.2...